EFEMP1 and liver disorder: Finally, studying serum EVs hasidentified fibulin-3 as a new predictor of liver-related events inmetabolic-associated steatotic liver disease. Overall, EVs offer a dynamic and noninvasive approach totracking liver disease progression and response to treatment.